| Device Type ID | 6043 |
| Device Name | Enzyme Immunoassay, Opiates |
| Regulation Description | Opiate Test System. |
| Regulation Medical Specialty | Toxicology |
| Review Panel | Toxicology |
| Premarket Review | Office Of In Vitro Diagnostics And Radiological Health (OIR) |
| Submission Type | 510(k) |
| CFR Regulation Number | 862.3650 [🔎] |
| FDA Device Classification | Class 2 Medical Device |
| Product Code | DJG |
| GMP Exempt | No |
| Summary MR | Eligible |
| Implanted Device | No |
| Life Support Device | No |
| Third Party Review | Eligible For Accredited Persons Program |
| Device Type ID | 6043 |
| Device | Enzyme Immunoassay, Opiates |
| Product Code | DJG |
| FDA Device Classification | Class 2 Medical Device |
| Regulation Description | Opiate Test System. |
| CFR Regulation Number | 862.3650 [🔎] |
| Premarket Reviews | ||
|---|---|---|
| Manufacturer | Decision | |
ADVIN BIOTECH, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
BIOPHOR DIAGNOSTICS, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
CO-INNOVATION BIOTECH CO.,LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
GUANGZHOU WONDFO BIOTECH CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
HANMEDICS CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
HEALGEN SCIENTIFIC LLC | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
IMMUNALYSIS CORPORATION | ||
SUBSTANTIALLY EQUIVALENT | 6 | |
LIN-ZHI INTERNATIONAL, INC. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
OMEGA LABORATORIES, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
PRINCETON BIOMEDITECH CORP. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
SHANGHAI CHEMTRON BIOTECH CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
SIEMENS | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
SIEMENS HEALTHCARE DIAGNOSTICS INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
SIEMENS HEALTHCARE DIAGNOSTICS, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
THERMO FISHER SCIENTIFIC | ||
SUBSTANTIALLY EQUIVALENT | 4 | |
| Recalls | |||
|---|---|---|---|
| Manufacturer | Recall Class | Date Posted | |
| 1 | Lin-Zhi International Inc | III | Mar-21-2014 |
| 2 | Siemens Healthcare Diagnostics, Inc. | III | May-10-2018 |